Re:DeepMind readies first commercial product
by eismcc on Sunday March 31, 2019 @11:23PM
(#19540204)
This assumes that’s what medical companies want. If we get closer to full value based care, then yes.
[ Parent
| on HN ]
Re:DeepMind readies first commercial product
by xiphias2 on Monday April 01, 2019 @12:07AM
(#19540412)
Which medical company doesn't want to move costs down?
You don't need high costs to charge a lot.
Re:DeepMind readies first commercial product
by eismcc on Monday April 01, 2019 @12:22AM
(#19540480)
If your business is making money on treating issues, preventing them isn’t aligned. Worst case, you neglect issues until they get to a point where you start making money. Legacy dialysis business is a good exsmple - they need ass-in-seats to justify clinics, so prevention isn’t as big a priority. Also, doctors often have shares in clinic revenue.
Re:DeepMind readies first commercial product
by sergers on Monday April 01, 2019 @02:06AM
(#19540911)
A friend of mind works for a software company that was utilizing Medq AI's brain bleed/hemorrhage detection Algorithm to identify urgent cases to be reviewed by a radiologist.
They were pitching it to a medical group, and they were like that's great for patient care but how does it cut costs to the organization...
Re:DeepMind readies first commercial product
by xiphias2 on Monday April 01, 2019 @11:08AM
(#19544052)
This makes sense, but Facebook / Google have enough resources to push their solutions onto the hospitals (give few years for free, maybe give the CEO some other fun stuff).
MRI manufacturers want to develop products that bring on new functionality and ability to justify their prices. A brand new 1.5T scanner easily costs several MIL to make, and for a clinic to purchase one will have to fulfill a business case to justify the purchase. For the clinics, acquiring new service lines (such as adding cardiac) is one such way to do so even in a more value based care setting.